Real life experience on the effect of Belimumab in patients with active systemic lupus.
BACKGROUND
To evaluate real life experience on the effect of Belimumab in patients with active systemic lupus erythematosus.


METHODS
Twenty patinets with musclesketal symptoms were evaluated, three were discontinued for different resons and seventeen completed eight injections of Belimumab during a six month period. A fatigue score was also evaluated at the same time.


RESULTS
Marked reduction of disease activity and fatigue score were observed in the patient group.


CONCLUSIONS
Belimumab is a novel form of therapy in patients with active systemic lupus erythematosus to be added in the standard of care particularly in patients with skin and joint symptoms.
Clinical Research Center Hospital AACD, São Paulo, 04032-060 Brazil.
Morton
M
Scheinberg
Clinical Research Center Hospital AACD, São Paulo, 04032-060 Brazil.
Ricardo
R
Golmia